These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7993800)

  • 1. Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation.
    Kurantsin-Mills J; Ibe BO; Natta CL; Raj JU; Siegel RS; Lessin LS
    Br J Haematol; 1994 Jul; 87(3):580-5. PubMed ID: 7993800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.
    Obilade OA; Akanmu AS; Broughton Pipkin F; Afolabi BB
    PLoS One; 2017; 12(9):e0184345. PubMed ID: 28880908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
    Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
    J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thromboxane B2 levels and thromboxane B2 production by platelets are increased in patients during spinal and epidural anesthesia.
    Kaukinen S; Ojanen R; Kaukinen L; Seppälä E; Vapaatalo H
    Prostaglandins Leukot Essent Fatty Acids; 1989 Aug; 37(2):83-8. PubMed ID: 2780766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
    Setty BN; Chen D; Stuart MJ
    Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites.
    Eldor A; Lellouche F; Goldfarb A; Rachmilewitz EA; Maclouf J
    Blood; 1991 Apr; 77(8):1749-53. PubMed ID: 2015401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status.
    Vericel E; Croset M; Sedivy P; Courpron P; Dechavanne M; Lagarde M
    Thromb Res; 1988 Feb; 49(3):331-42. PubMed ID: 3129819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619.
    Foulon I; Bachir D; Galacteros F; Maclouf J
    Arterioscler Thromb; 1993 Mar; 13(3):421-6. PubMed ID: 8443146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
    Yoshida T; Ichikawa Y; Tojo T; Homma M
    Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
    Nowak J; FitzGerald GA
    J Clin Invest; 1989 Feb; 83(2):380-5. PubMed ID: 2643628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
    Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
    Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty.
    Vesterqvist O; Schött U; Berséus O; Axelsson K; Gréen K
    Scand J Clin Lab Invest; 1988 May; 48(3):233-9. PubMed ID: 3375779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.